Atelvia Approval History 
- FDA approved: Yes (First approved October 8th, 2010)
- Brand name: Atelvia
- Generic name: risedronate sodium
- Company: Warner Chilcott
- Treatment for: Osteoporosis
Atelvia (risedronate sodium) is a bisphosphonate in a delayed-release formulation for treatment of postmenopausal osteoporosis.
FDA Approval History for Atelvia
| Date | Article |
|---|---|
| Oct 11, 2010 |  Warner Chilcott Announces FDA Approval of Atelvia - Next Generation Actonel |
See also...
Atelvia (risedronate sodium) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
